Guidelines for the collection of samples for primaquine / carboxyprimaquine pharmacology analysis
These guidelines aim to standardize the sample collection procedure during clinical studies of primaquine / carboxyprimaquine antimalarial drugs
Publication Version
2.0
Publication Code
CL21
The purpose of this document is to standardize the sample collection procedure during clinical studies of primaquine / carboxyprimaquine antimalarial drugs. This should be considered as a recommendation, created by WWARN, aiming to achieve homogeneous quality in the pre-analytical phase of studies and to provide guidelines in the processes of collection, processing, preserving, storage, shipment and safe handling of samples from human origin.